65 related articles for article (PubMed ID: 11894800)
1. Evaluating changes in sexual functioning in depressed patients: sensitivity to change of the CSFQ.
Bobes J; González MP; Bascarán MT; Clayton A; Garcia M; Rico-Villade Moros F; Banús S
J Sex Marital Ther; 2002; 28(2):93-103. PubMed ID: 11894800
[TBL] [Abstract][Full Text] [Related]
2. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.
Montejo AL; Llorca G; Izquierdo JA; Rico-Villademoros F
J Clin Psychiatry; 2001; 62 Suppl 3():10-21. PubMed ID: 11229449
[TBL] [Abstract][Full Text] [Related]
3. Resolution of sexual dysfunction during acute treatment of major depression with milnacipran.
Baldwin D; Moreno RA; Briley M
Hum Psychopharmacol; 2008 Aug; 23(6):527-32. PubMed ID: 18536065
[TBL] [Abstract][Full Text] [Related]
4. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
Baldwin D; Bridgman K; Buis C
J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
[TBL] [Abstract][Full Text] [Related]
5. Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder.
Clayton AH; Segraves RT; Leiblum S; Basson R; Pyke R; Cotton D; Lewis-D'Agostino D; Evans KR; Sills TL; Wunderlich GR
J Sex Marital Ther; 2006; 32(2):115-35. PubMed ID: 16418104
[TBL] [Abstract][Full Text] [Related]
6. Assessment of paroxetine-induced sexual dysfunction using the Changes in Sexual Functioning Questionnaire.
Clayton AH; Owens JE; McGarvey EL
Psychopharmacol Bull; 1995; 31(2):397-413. PubMed ID: 7491398
[TBL] [Abstract][Full Text] [Related]
7. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14).
Keller A; McGarvey EL; Clayton AH
J Sex Marital Ther; 2006; 32(1):43-52. PubMed ID: 16234225
[TBL] [Abstract][Full Text] [Related]
8. The effect of gepirone-ER in the treatment of sexual dysfunction in depressed men.
Fabre LF; Clayton AH; Smith LC; Goldstein I; Derogatis LR
J Sex Med; 2012 Mar; 9(3):821-9. PubMed ID: 22240272
[TBL] [Abstract][Full Text] [Related]
9. Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ).
Clayton AH; McGarvey EL; Clavet GJ; Piazza L
Psychopharmacol Bull; 1997; 33(4):747-53. PubMed ID: 9493487
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA
J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study of sexual functioning in women referred for colposcopy: a 2-year follow up.
Hellsten C; Lindqvist PG; Sjöström K
BJOG; 2008 Jan; 115(2):205-11. PubMed ID: 17903228
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
13. Time course of depression-symptom improvement during treatment with duloxetine.
Hirschfeld RM; Mallinckrodt C; Lee TC; Detke MJ
Depress Anxiety; 2005; 21(4):170-7. PubMed ID: 16035056
[TBL] [Abstract][Full Text] [Related]
14. Validated instruments for assessing female sexual function.
Meston CM; Derogatis LR
J Sex Marital Ther; 2002; 28 Suppl 1():155-64. PubMed ID: 11898697
[TBL] [Abstract][Full Text] [Related]
15. Major depressive disorder, antidepressants, and sexual dysfunction.
Clayton AH; Montejo AL
J Clin Psychiatry; 2006; 67 Suppl 6():33-7. PubMed ID: 16848675
[TBL] [Abstract][Full Text] [Related]
16. Sexual function in adult patients with spina bifida and its impact on quality of life.
Lassmann J; Garibay Gonzalez F; Melchionni JB; Pasquariello PS; Snyder HM
J Urol; 2007 Oct; 178(4 Pt 2):1611-4. PubMed ID: 17707040
[TBL] [Abstract][Full Text] [Related]
17. Sexual functioning and patient expectations of sexual functioning after hysterectomy.
Dragisic KG; Milad MP
Am J Obstet Gynecol; 2004 May; 190(5):1416-8. PubMed ID: 15167854
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Spanish version of the Changes in Sexual Functioning Questionnaire (CSFQ).
Bobes J; Gonzalez MP; Rico-Villandemoros F; Bascaran MT; Sarasa P; Clayton A
J Sex Marital Ther; 2000; 26(2):119-31. PubMed ID: 10782444
[TBL] [Abstract][Full Text] [Related]
19. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
[TBL] [Abstract][Full Text] [Related]
20. The menopause and sexual functioning: a review of the population-based studies.
Dennerstein L; Alexander JL; Kotz K
Annu Rev Sex Res; 2003; 14():64-82. PubMed ID: 15287158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
